CME Stock Cash Flow Statements

CME Group Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

CME Group Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31

cash flows from operating activities
net income	1,025,100,000	956,200,000	874,600,000	912,800,000	883,200,000	855,200,000	814,600,000	750,200,000	777,600,000	883,800,000	637,900,000	679,600,000	662,500,000	711,000,000	625,200,000	926,300,000	510,600,000	574,800,000	424,800,000	411,500,000	503,300,000	766,800,000	469,000,000	636,300,000	514,600,000	495,900,000	387,000,000	411,800,000	566,100,000	598,800,000	2,939,200,000	308,600,000	415,800,000	399,800,000	373,400,000	472,800,000	320,100,000	367,800,000	291,700,000	359,900,000	265,000,000	330,400,000	306,500,000	290,000,000	263,800,000	266,600,000	193,100,000	236,300,000	311,300,000	237,400,000	168,100,000	218,900,000	253,400,000	266,300,000	746,700,000	315,000,000	295,600,000	457,100,000	196,400,000	244,300,000	271,200,000	240,200,000	202,600,000	202,300,000	221,800,000	199,100,000	62,065,000
adjustments to reconcile net income to net cash from operating activities:
stock-based compensation	20,700,000	21,200,000	27,100,000	20,300,000	18,800,000	23,300,000	24,300,000	18,900,000	19,500,000	20,200,000	25,500,000	19,400,000	19,400,000	20,000,000	18,600,000	15,600,000	19,400,000	21,600,000	26,700,000	23,800,000	22,400,000	23,100,000	2,300,000	14,400,000	38,100,000	18,300,000	46,000,000	16,600,000	16,200,000	17,700,000	15,200,000	15,100,000	12,800,000	14,900,000	23,900,000	12,300,000	14,000,000	16,000,000	15,600,000	11,500,000	19,000,000	14,700,000	13,900,000	14,500,000	13,200,000	13,200,000	14,000,000	14,400,000	13,600,000	12,400,000	12,600,000	13,800,000	20,700,000	14,300,000	13,800,000	12,800,000	12,700,000	12,000,000	13,000,000	9,000,000	9,600,000	9,300,000	9,800,000	6,700,000	8,300,000	8,600,000	11,284,000
amortization of purchased intangibles	56,100,000	55,200,000	55,300,000	55,700,000	55,500,000	55,200,000	55,600,000	57,200,000	57,000,000	56,800,000	56,700,000	55,500,000	57,100,000	58,400,000	58,600,000	59,000,000	59,400,000	60,600,000	79,000,000	78,300,000	76,600,000	77,300,000	78,100,000	79,800,000	76,100,000	80,700,000	59,000,000	23,700,000	23,600,000	23,700,000	23,700,000	23,800,000	24,000,000	24,000,000	24,100,000	24,000,000	24,000,000	24,000,000	24,600,000	24,900,000	25,000,000	24,900,000	24,900,000	25,300,000	25,200,000	25,200,000	25,600,000	25,600,000	25,900,000	25,900,000	25,900,000	26,200,000	31,300,000	32,800,000	32,800,000	33,000,000	33,000,000	33,200,000	32,600,000	32,400,000	32,300,000	30,800,000	30,600,000	30,700,000	30,500,000	33,300,000	35,524,000
depreciation and amortization	27,300,000	27,300,000	28,100,000	28,200,000	28,700,000	30,100,000	30,700,000	31,100,000	32,300,000	31,900,000	33,900,000	34,500,000	33,000,000	33,500,000	35,900,000	37,200,000	37,100,000	37,600,000	41,500,000	39,700,000	36,700,000	35,300,000	38,000,000	41,400,000	46,300,000	32,900,000	32,900,000	30,200,000	27,500,000	28,100,000	27,900,000	26,900,000	28,800,000	29,400,000	33,700,000	31,200,000	30,400,000	33,900,000	31,700,000	32,400,000	33,300,000	31,800,000	31,500,000	32,700,000	34,300,000	34,100,000	34,300,000	35,000,000	33,200,000	32,600,000	33,900,000	34,500,000	33,600,000	34,900,000	33,400,000	32,400,000	31,700,000	31,000,000	31,800,000	33,100,000	32,800,000	32,200,000	32,900,000	32,300,000	30,100,000	31,000,000	34,472,000
net realized and unrealized (gains) losses on investments	0	-2,600,000		0	-9,200,000	-2,500,000		1,900,000	1,100,000	-74,800,000		-1,100,000	500,000	-3,500,000		-91,300,000
deferred income taxes	-13,300,000	-7,400,000	-44,500,000	-7,400,000	-7,100,000	-7,400,000	-49,200,000	-8,600,000	-8,500,000	-8,700,000	-1,100,000	-10,100,000	-6,900,000	-5,100,000	21,000,000	-5,400,000	27,000,000	-7,800,000	-23,000,000	3,500,000	-12,400,000	-9,700,000	20,000,000	-10,600,000	-12,500,000	-600,000	89,700,000	19,600,000	16,700,000	-11,700,000	-2,575,300,000	117,900,000	9,600,000	2,200,000	-3,700,000	-101,300,000	22,400,000	-400,000	13,500,000	8,500,000	40,800,000	500,000	15,800,000	45,600,000	-8,300,000	25,800,000	-51,100,000	55,900,000	-3,500,000	-7,300,000	14,600,000	22,600,000	64,200,000	-19,200,000	-527,900,000	20,900,000	400,000	-152,100,000	53,600,000	-13,500,000	-10,600,000	-7,200,000	-28,000,000	-15,900,000	-3,500,000	-9,500,000	-82,932,000
change in:
accounts receivable	101,400,000	-196,800,000	55,800,000	-29,700,000	27,900,000	-93,400,000	23,400,000	40,800,000	125,500,000	-241,200,000	96,300,000	600,000	26,000,000	-174,000,000	36,100,000	50,700,000	13,700,000	-146,200,000	29,000,000	41,700,000	267,000,000	-309,500,000	53,400,000	47,800,000	-34,900,000	-5,500,000	-37,600,000	47,100,000	10,000,000	-85,000,000	29,800,000	26,800,000	10,900,000	-61,500,000	10,600,000	52,400,000	-37,800,000	-33,300,000	5,000,000	36,100,000	-16,600,000	-41,800,000	3,400,000	-10,000,000	10,000,000	-41,900,000	9,500,000	47,100,000	-50,000,000	-42,100,000	32,100,000	41,200,000	-3,300,000	-70,300,000	59,300,000	15,500,000	8,400,000	-96,400,000	35,200,000	1,100,000	-16,700,000	-48,300,000	15,800,000	18,100,000	-3,200,000	-45,100,000	107,192,000
other current assets			66,100,000	-41,400,000	176,100,000	464,000,000	-534,900,000	-88,300,000	-69,300,000	54,700,000	-47,000,000	-10,500,000	50,700,000	-69,700,000	-14,400,000	-18,700,000	8,200,000	-30,500,000	68,100,000	-39,500,000	16,300,000	-14,500,000	216,700,000	-232,600,000	80,700,000	45,400,000	-120,100,000	-1,300,000	49,400,000	-12,900,000	31,500,000	-25,000,000	6,700,000	-9,300,000	15,700,000	-18,500,000	6,100,000	-100,000	-25,100,000	4,300,000	3,200,000	4,900,000	13,100,000	-5,400,000	-9,900,000	5,900,000	-9,500,000	-21,700,000	4,600,000	24,000,000	17,900,000	-40,400,000	2,600,000	1,700,000	-54,300,000	13,400,000	-27,500,000	-1,000,000	-44,900,000	-1,800,000	23,400,000	-6,600,000	1,000,000	1,200,000	-25,500,000	15,900,000	-53,718,000
other assets	13,300,000	16,500,000	37,300,000	18,800,000	19,500,000	-200,000	33,400,000	7,800,000	31,400,000	19,400,000	10,300,000	24,600,000	33,100,000	19,000,000	19,700,000	10,500,000	18,800,000	12,300,000	26,500,000	17,300,000	9,000,000	18,800,000	39,700,000	2,900,000	-3,600,000	-9,800,000	21,900,000	8,600,000	3,000,000	-3,800,000	-77,300,000	10,900,000	41,600,000	7,000,000	-4,100,000	29,800,000	-14,400,000	-5,900,000	14,400,000	-3,300,000	-3,900,000	-11,200,000	-600,000	-14,700,000	-12,400,000	16,200,000	-29,300,000	-14,700,000	19,200,000	25,400,000	-31,500,000	-16,900,000	-7,000,000	4,700,000	-16,200,000	9,600,000	-1,000,000	-19,500,000	-10,900,000	18,700,000	-1,100,000	-12,800,000	700,000	4,400,000	-8,300,000	-3,700,000	-31,885,000
accounts payable	-7,800,000	20,300,000	-50,000,000	30,000,000	-11,200,000	20,500,000	36,700,000	2,900,000	-46,200,000	-24,200,000	26,300,000	14,200,000	0	32,000,000	-22,200,000	24,600,000	-12,300,000	-8,700,000	-30,200,000	11,500,000	13,700,000	12,400,000	300,000	9,900,000	-13,700,000	-50,600,000	9,800,000	26,000,000	2,900,000	-6,400,000	-4,900,000	10,700,000	-12,900,000	12,200,000	-8,300,000	-1,100,000	3,300,000	3,500,000	-9,500,000	16,100,000	-11,800,000	-3,000,000	1,900,000	2,900,000	-11,000,000	6,900,000	-4,800,000	4,000,000	5,700,000	-10,400,000	-2,800,000	5,500,000	10,600,000	-2,100,000	-9,700,000	1,100,000	-18,700,000	6,300,000	8,100,000	6,200,000	2,200,000	-10,400,000	10,600,000	-2,400,000	-8,000,000	-24,500,000	17,882,000
income taxes payable	-252,600,000	280,900,000	10,600,000	-21,800,000	-257,600,000	151,400,000	9,400,000	-36,500,000	-332,500,000	282,500,000	20,000,000	-115,600,000	-218,100,000	165,900,000	-32,200,000	-4,600,000	-199,400,000	115,700,000	31,700,000	-321,000,000	107,900,000	186,100,000	65,900,000	-65,900,000	-169,900,000	141,300,000	34,400,000	-10,000,000	-93,800,000	264,800,000	89,700,000	12,400,000	-266,700,000	168,100,000	39,200,000	34,100,000	-191,300,000	178,500,000	-12,000,000	-14,600,000	-204,600,000	149,100,000	35,800,000	-113,900,000	-160,100,000	132,600,000	76,600,000	-121,600,000	-113,300,000	149,000,000	48,600,000	-23,200,000	-128,400,000	174,900,000						-20,300,000
other current liabilities	125,000,000	-57,100,000	-14,500,000	27,000,000	-113,100,000	-605,300,000	586,200,000	79,200,000	84,000,000	-106,700,000	87,700,000	-5,200,000	-700,000	6,300,000	41,900,000	-4,500,000	56,800,000	-32,300,000	-14,700,000	16,300,000	-33,800,000	-22,100,000	-191,200,000	269,600,000	-104,600,000	-73,100,000	1,000,000	-11,400,000	-26,700,000	300,000	14,400,000	2,200,000	42,300,000	-67,800,000	28,100,000	-26,000,000	46,800,000	-88,100,000	10,200,000	-5,100,000	59,200,000	-85,400,000	16,500,000	-7,400,000	40,200,000	-95,400,000	51,200,000	-116,900,000	144,100,000	-35,900,000	36,100,000	-41,300,000	44,800,000	-45,200,000	49,000,000	-31,400,000	46,900,000	-71,000,000	65,100,000	-17,700,000	60,000,000	-27,800,000	32,900,000	-12,000,000	5,900,000	-50,100,000	-9,761,000
other liabilities	-6,400,000	-2,800,000	-38,400,000	-1,800,000	-13,400,000	-1,800,000	1,800,000	-16,100,000	-11,200,000	-7,200,000	-6,600,000	-21,800,000	-24,300,000	-14,700,000	-17,900,000	-9,600,000	-8,700,000	-8,600,000	-2,600,000	22,900,000	-19,600,000	-29,500,000	-53,800,000	-7,500,000	8,200,000	300,000	-10,300,000	-4,300,000	-5,600,000	-300,000	-11,400,000	300,000	0	2,600,000	-8,200,000	-9,000,000	2,200,000	-7,500,000	-9,300,000	-400,000	1,800,000	-1,900,000	8,400,000	-10,300,000	-4,500,000	3,600,000	-9,800,000	4,200,000			-22,300,000	7,400,000	2,300,000	2,300,000	-1,500,000	7,900,000	4,400,000	2,400,000	-16,400,000	14,500,000	-600,000	7,800,000	1,100,000	7,600,000	20,400,000	1,600,000	1,435,000
other		5,700,000	2,300,000	12,300,000	-21,200,000	3,600,000	12,600,000	16,200,000	-10,300,000	15,900,000	42,300,000	-10,200,000	1,100,000	8,100,000	1,100,000	1,100,000	300,000	1,900,000	2,000,000	1,200,000	1,300,000	4,100,000	2,600,000	700,000	9,800,000	-1,200,000	9,300,000	800,000	400,000	800,000	1,600,000	-600,000	-500,000	100,000	1,000,000	-5,900,000			1,300,000	600,000	1,100,000	2,600,000	800,000	4,900,000	-600,000	1,200,000	-1,100,000	2,600,000	2,100,000	2,500,000	-800,000	1,000,000	-300,000	-300,000	-900,000	900,000	-200,000	-100,000	900,000	2,600,000	-700,000	-1,000,000
net cash from operating activities	1,058,500,000	1,116,600,000	1,017,900,000	1,003,000,000	776,900,000	892,700,000	1,044,300,000	856,700,000	650,400,000	902,400,000	981,500,000	657,800,000	617,600,000	799,100,000	668,300,000	631,600,000	499,800,000	602,700,000	660,300,000	311,400,000	986,800,000	757,100,000	719,700,000	810,200,000	473,700,000	669,200,000	510,400,000	582,600,000	522,800,000	825,000,000	510,200,000	507,200,000	304,300,000	518,700,000	510,400,000	462,400,000	223,500,000	519,700,000	374,100,000	463,500,000	258,800,000	418,900,000	502,500,000	234,200,000	171,700,000	383,000,000	381,900,000	129,800,000	372,800,000	396,000,000	319,600,000	239,400,000	262,200,000	395,600,000	346,500,000	423,700,000	214,000,000	362,100,000	393,400,000	313,900,000	293,400,000	355,700,000	345,300,000	299,400,000	183,700,000	254,700,000	334,485,000
capex	-18,400,000	-14,200,000	-26,200,000	-29,800,000	-18,200,000	-19,800,000	-20,800,000	-19,900,000	-20,500,000	-15,200,000	-24,400,000	-24,000,000	-17,900,000	-23,400,000	-27,300,000	-31,700,000	-39,700,000	-28,500,000	-70,000,000	-48,300,000	-36,400,000	-42,800,000	-66,400,000	-57,600,000	-72,500,000	-49,100,000	-55,800,000	-31,300,000	-11,400,000	-18,200,000	-28,900,000	-15,400,000	-17,600,000	-20,000,000	-28,900,000	-23,300,000	-19,400,000	-20,200,000	-23,900,000	-29,600,000	-29,300,000	-31,400,000	-36,500,000	-26,800,000	-40,900,000	-36,500,000	-30,900,000	-38,900,000	-35,600,000	-20,200,000	-37,900,000	-40,300,000	-36,900,000	-26,700,000	-42,800,000	-41,000,000	-47,000,000	-41,400,000	-62,300,000	-43,900,000	-27,500,000	-26,300,000	-45,000,000	-33,900,000	-43,700,000	-35,300,000	-80,704,000
free cash flows	1,040,100,000	1,102,400,000	991,700,000	973,200,000	758,700,000	872,900,000	1,023,500,000	836,800,000	629,900,000	887,200,000	957,100,000	633,800,000	599,700,000	775,700,000	641,000,000	599,900,000	460,100,000	574,200,000	590,300,000	263,100,000	950,400,000	714,300,000	653,300,000	752,600,000	401,200,000	620,100,000	454,600,000	551,300,000	511,400,000	806,800,000	481,300,000	491,800,000	286,700,000	498,700,000	481,500,000	439,100,000	204,100,000	499,500,000	350,200,000	433,900,000	229,500,000	387,500,000	466,000,000	207,400,000	130,800,000	346,500,000	351,000,000	90,900,000	337,200,000	375,800,000	281,700,000	199,100,000	225,300,000	368,900,000	303,700,000	382,700,000	167,000,000	320,700,000	331,100,000	270,000,000	265,900,000	329,400,000	300,300,000	265,500,000	140,000,000	219,400,000	253,781,000
cash flows from investing activities
proceeds from maturities of available-for-sale marketable securities	1,200,000	3,600,000		1,600,000	1,600,000	1,700,000		800,000	2,900,000	700,000		1,200,000	1,200,000	2,700,000		1,700,000	3,500,000	2,200,000		1,900,000	5,300,000	2,200,000		1,400,000	5,500,000	6,100,000		3,200,000	1,800,000	1,600,000		1,100,000	700,000	500,000		3,700,000	4,600,000	31,800,000		10,200,000	8,900,000	10,200,000		10,200,000	9,000,000	9,300,000			9,000,000	8,500,000		6,100,000	200,000	9,100,000	5,300,000	200,000	300,000	5,500,000	400,000	5,400,000	600,000	5,500,000	50,700,000	20,400,000	200,000,000	168,700,000
purchases of available-for-sale marketable securities	-800,000	-3,000,000	-200,000	-1,300,000	-1,800,000	-1,200,000	-1,100,000	-400,000	-2,300,000	-300,000	-700,000	-800,000	-700,000	-2,200,000	-1,600,000	-1,300,000	-3,400,000	-1,500,000	-2,400,000	-2,000,000	-4,300,000	-2,400,000	-5,600,000	-1,500,000	-2,700,000	-5,600,000	-5,000,000	-3,100,000	-1,100,000	-800,000	-700,000	-1,800,000			-1,000,000	-4,600,000	-4,400,000	-35,900,000	-6,000,000	-10,100,000	-9,000,000	-10,200,000	-9,000,000	-10,200,000	-9,000,000	-10,100,000	-9,000,000	-9,300,000	-9,000,000	-9,300,000	-9,000,000				-5,100,000	0	0	-5,100,000	0	-5,100,000	0	-5,100,000	0	-5,100,000	-50,000,000	-104,800,000
purchases of property	-18,400,000	-14,200,000	-26,200,000	-29,800,000	-18,200,000	-19,800,000	-20,800,000	-19,900,000	-20,500,000	-15,200,000	-24,400,000	-24,000,000	-17,900,000	-23,400,000	-27,300,000	-31,700,000	-39,700,000	-28,500,000	-70,000,000	-48,300,000	-36,400,000	-42,800,000	-66,400,000	-57,600,000	-72,500,000	-49,100,000	-55,800,000	-31,300,000	-11,400,000	-18,200,000	-28,900,000	-15,400,000	-17,600,000	-20,000,000	-28,900,000	-23,300,000	-19,400,000	-20,200,000	-23,900,000	-29,600,000	-29,300,000	-31,400,000	-36,500,000	-26,800,000	-40,900,000	-36,500,000	-30,900,000	-38,900,000	-35,600,000	-20,200,000	-37,900,000	-40,300,000	-36,900,000	-26,700,000	-42,800,000	-41,000,000	-47,000,000	-41,400,000	-62,300,000	-43,900,000	-27,500,000	-26,300,000	-45,000,000	-33,900,000	-43,700,000	-35,300,000	-80,704,000
investments in privately-held equity investments	0	-2,400,000		0	-100,000	-3,500,000		0	0	-2,400,000		0				0				-4,100,000
proceeds from sales of investments				0				0				0				85,900,000				8,600,000
net cash from investing activities	-18,000,000	-16,000,000	-25,300,000	-29,500,000	-5,000,000	-22,800,000	-20,400,000	-19,500,000	78,000,000	-17,200,000	-25,700,000	-23,600,000	-417,600,000	-22,900,000	67,600,000	58,800,000	-34,000,000	-34,000,000	-52,100,000	-43,900,000	-36,500,000	-43,000,000	-15,900,000	-46,800,000	-41,300,000	-48,600,000	-1,850,700,000	-31,200,000	9,700,000	-17,400,000	-20,900,000	-4,000,000	-19,400,000	224,200,000	117,500,000	-16,500,000	-20,000,000	-27,300,000	39,200,000	-20,200,000	23,300,000	-24,400,000	-91,500,000	-37,300,000	-40,900,000	-29,400,000	157,500,000	89,600,000	-35,600,000	-21,000,000	-156,400,000	-121,400,000	112,200,000	-40,400,000	-42,600,000	-40,800,000	-28,600,000	-41,600,000	-39,700,000	-61,000,000	12,100,000	-19,800,000	5,400,000	-18,500,000	256,900,000	301,000,000	-303,638,000
cash flows from financing activities
proceeds from debt, net of issuance costs	0	742,300,000									0	0	-1,700,000	742,700,000														-1,900,000												0	0	743,700,000
repayment of debt	0	-750,000,000																						0	0	-569,200,000														0				0	0	-750,000,000
cash dividends	-455,300,000	-2,567,400,000	-418,800,000	-418,500,000	-418,500,000	-2,328,400,000	-400,100,000	-400,000,000	-399,800,000	-2,035,600,000	-363,500,000	-363,200,000	-363,300,000	-1,543,500,000	-326,800,000	-322,500,000	-322,500,000	-1,217,500,000	-304,300,000	-304,100,000	-304,000,000	-1,197,600,000	-268,100,000	-267,900,000	-267,800,000	-892,100,000	-249,800,000	-237,600,000	-237,700,000	-1,424,800,000	-223,900,000	-223,500,000	-223,500,000	-1,322,600,000	-202,900,000	-202,600,000	-202,400,000	-1,179,300,000	-168,500,000	-168,200,000	-167,900,000	-838,800,000	-157,600,000	-157,100,000	-157,100,000	-1,025,000,000	-149,500,000	-149,800,000	-150,400,000	-149,400,000	-580,000,000	-150,100,000	-147,700,000	-346,500,000	-92,200,000	-93,100,000	-93,900,000	-93,600,000	-77,000,000	-76,800,000	-75,600,000	-75,900,000	-76,600,000	-76,400,000	-76,300,000	-76,300,000	-412,454,000
repurchase of class a common stock, including costs																																																							0	-155,100,000			-100,000	-279,000,000	-14,400,000	-281,800,000		0	0	-27,000,000
change in performance bond and guaranty fund contributions	21,463,400,000	21,799,100,000	-561,600,000	13,787,000,000	-8,803,900,000	4,281,400,000	3,000,400,000	-26,049,400,000	-14,849,200,000	-7,158,500,000	-4,725,600,000	1,544,500,000	-29,306,300,000	9,787,100,000
employee taxes paid on restricted stock vesting	-600,000	-8,200,000	-3,500,000	-17,100,000	-100,000	-12,300,000	-2,900,000	-17,400,000	-800,000	-300,000	-3,100,000	-16,400,000	-1,000,000	-4,300,000	-500,000	-17,700,000	-400,000	-13,100,000	-4,300,000	-17,700,000	-300,000	-19,100,000	0	-22,700,000	-300,000	-13,800,000	-100,000	-20,000,000	-200,000	-14,700,000	-800,000	-18,400,000	-500,000	-11,600,000
net cash from financing activities	20,999,200,000	19,211,400,000	-984,100,000	13,347,000,000	-9,222,800,000	1,936,400,000	2,588,500,000	-26,466,800,000	-15,262,500,000	-9,198,500,000	-5,091,200,000	1,160,600,000	-29,672,700,000	8,221,600,000	71,805,100,000	-342,100,000	-321,100,000	-1,233,200,000	-307,000,000	-340,700,000	-396,600,000	-1,413,900,000	-363,300,000	-490,200,000	-489,600,000	-997,700,000	-312,200,000	-257,500,000	925,000,000	-1,435,300,000	-216,800,000	-234,400,000	-210,400,000	-1,323,700,000	-179,800,000	-186,500,000	-188,400,000	-1,039,000,000	-155,000,000	-160,000,000	-825,900,000	-65,800,000	-132,800,000	-146,300,000	-147,200,000	-1,769,600,000	-134,700,000	-122,400,000	-212,600,000	-136,300,000	-575,400,000	605,700,000	-142,900,000	-335,800,000	-90,900,000	-247,200,000	-156,500,000	-511,000,000	-66,700,000	-48,300,000	-386,100,000	-152,300,000	-294,200,000	-525,500,000	-331,100,000	-514,400,000	-315,373,000
net change in cash, cash equivalents, restricted cash and restricted cash equivalents	22,039,700,000	20,312,000,000	8,500,000	14,320,500,000	-8,450,900,000	2,806,300,000	3,612,400,000	-25,629,600,000	-14,534,100,000	-8,313,300,000	-4,135,400,000	1,794,800,000	-29,472,700,000	8,997,800,000
cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of period	0	101,794,100,000	0	0	0	93,109,700,000	-100,000	100,000	0	137,974,300,000	-100,000	0	0	160,789,900,000
cash, cash equivalents, restricted cash and restricted cash equivalents, end of period	22,039,700,000	122,106,100,000	8,500,000	14,320,500,000	-8,450,900,000	95,916,000,000	3,612,300,000	-25,629,500,000	-14,534,100,000	129,661,000,000	-4,135,500,000	1,794,800,000	-29,472,700,000	169,787,700,000
reconciliation of cash, cash equivalents, restricted cash and restricted cash equivalents:
cash and cash equivalents	576,000,000	1,405,300,000	570,300,000	532,200,000	353,000,000	1,436,900,000	611,800,000	420,100,000	314,900,000	1,565,200,000	590,000,000	250,600,000	-166,200,000	2,045,700,000	1,375,500,000	378,400,000	144,600,000	936,400,000	301,100,000	-73,300,000	553,700,000	851,700,000	341,300,000	272,400,000	-59,700,000	997,400,000	-31,800,000	307,400,000	314,300,000	784,600,000
short-term restricted cash	200,000	6,300,000	-200,000	1,300,000	0	5,200,000	100,000	-100,000	100,000	5,100,000	300,000	-100,000	-100,000	4,800,000	0	0	300,000	4,500,000	200,000	100,000	100,000	4,300,000	-800,000	1,000,000	2,500,000	1,600,000	-1,620,600,000	-13,400,000	1,143,200,000	492,300,000
restricted cash and restricted cash equivalents	21,463,500,000	120,694,500,000	-561,600,000	13,787,000,000	-8,803,900,000	94,473,900,000	3,000,400,000	-26,049,500,000	-14,849,100,000	128,090,700,000	-4,725,700,000	1,544,500,000	-29,306,300,000	167,736,700,000
total	22,039,700,000	122,106,100,000	8,500,000	14,320,500,000	-8,450,900,000	95,916,000,000	3,612,300,000	-25,629,500,000	-14,534,100,000	129,661,000,000	-4,135,500,000	1,794,800,000	-29,472,700,000	169,787,700,000	159,322,800,000	348,300,000	144,700,000	974,000,000	301,200,000	-73,200,000	553,700,000	856,800,000	340,500,000	273,200,000	-57,200,000	1,000,100,000	-1,652,500,000	293,900,000	1,457,500,000	1,278,300,000
supplemental disclosure of cash flow information
income taxes paid	566,900,000	12,700,000	259,000,000	288,900,000	534,900,000	114,800,000	226,100,000	271,600,000	580,800,000	30,900,000	169,400,000	324,600,000	434,800,000	44,600,000	142,500,000	178,800,000	367,900,000	65,800,000	99,500,000	436,600,000	77,600,000	39,000,000	40,600,000	176,700,000			166,800,000	137,800,000	264,000,000	8,800,000	120,100,000	166,500,000	466,100,000	10,100,000	161,200,000	135,200,000	382,200,000	28,100,000	168,100,000	155,200,000	349,400,000	43,900,000	117,600,000	201,900,000	306,200,000	15,800,000	77,600,000	222,500,000	305,700,000	6,400,000	107,300,000	188,000,000	325,300,000	3,800,000	204,000,000	201,000,000	404,100,000	7,000,000	193,300,000	220,700,000			160,100,000	140,000,000	281,500,000	48,100,000
interest paid	23,900,000	41,100,000	23,900,000	41,000,000	23,900,000	41,100,000	23,900,000	41,000,000	23,900,000	41,100,000	24,500,000	41,400,000	23,900,000	43,400,000	23,900,000	42,300,000	24,700,000	42,400,000	23,900,000	42,400,000	24,600,000	42,400,000	23,900,000	42,300,000	24,700,000	55,400,000	23,500,000	42,400,000	0	42,400,000	0	42,400,000	0	42,400,000	0	42,400,000	0	42,400,000	0	42,800,000	1,700,000	44,600,000	0	44,600,000	0	66,800,000	0	66,500,000	0	66,900,000	0	55,300,000	0	55,300,000	0	55,300,000	0	56,600,000	1,600,000	57,200,000			2,600,000	47,200,000	5,000,000	36,000,000	6,424,000
net realized and unrealized (gains)/losses on investments
proceeds from maturities and sales of available-for-sale marketable securities
investments in business ventures																															0	-3,000,000	-2,000,000	-300,000	-4,200,000	-1,100,000	-800,000	-3,000,000	-9,700,000	-2,000,000			-48,800,000								39,300,000
proceeds from sale of business ventures
investment in s&p dow jones indices llc
repayment of other borrowings, including call premiums
long-term restricted cash											-100,000	-200,000	-100,000	500,000	-2,300,000	-100,000	-200,000	3,100,000	-100,000	0	-100,000	800,000	0	-200,000	0	1,100,000	-100,000	-100,000	0	1,400,000
non-cash financing activities:
declaration of annual variable dividend, payable in january 2025, january 2024 and january 2023
repayment of debt, including call premium								0				0	-100,000	-756,100,000
non-cash investing activities:
accrued proceeds from sale of investments										97,900,000
gain on sale of building
gain on joint venture
payment for acquisition of subsidiary's interests from the non-controlling interest
proceeds from the sale of building property
net cash proceeds from osttra joint venture transaction															57,000,000
proceeds from preferred stock offering
declaration of annual variable dividend, payable in january 2024, january 2023 and january 2022
investment in s&p/dow jones indices llc												0																																							0	923,400,000
net incomees on assets held for sale and impaired																							0
(gain)/loss on derivative contracts
repayment issuance of commercial paper
declaration of annual variable dividend, payable in january 2023, january 2022 and january 2021
gain on deconsolidation of optimization business
purchase of non-controlling interest																-39,500,000	-6,300,000	-6,200,000
cash dividends in excess of earnings (undistributed net earnings) of unconsolidated subsidiaries																	-11,200,000	13,100,000
cash classified as assets held for sale																	0	30,000,000
cash dividends in excess of earnings of unconsolidated subsidiaries														11,900,000
undistributed earnings, net of losses, of unconsolidated subsidiaries																										-22,600,000	-2,500,000	-1,100,000	-15,600,000	10,900,000	6,400,000	-20,800,000	-8,100,000	-4,300,000	27,000,000	-26,000,000	-7,500,000	4,200,000	10,100,000	-9,900,000	-8,600,000	3,300,000
repayment of other borrowings																																															0								0	0	0	-420,500,000	0				0				0
proceeds from settlement of derivative contract
declaration of annual variable dividend, payable in january 2021, january 2020 and january 2019
net incomees on impaired assets																				-500,000	4,800,000	23,100,000
net (gain) on derivative contracts
undistributed net earnings of unconsolidated subsidiaries																				800,000	-10,300,000	-200,000		-9,900,000
repayment of commercial paper
net change in cash, cash equivalents and restricted cash																348,300,000	144,700,000	-664,500,000	301,200,000	-73,200,000	553,700,000	-699,800,000	340,500,000	273,200,000	-57,200,000	-377,100,000	-1,652,500,000	293,900,000	1,457,500,000	-627,700,000
cash, cash equivalents and restricted cash, beginning of period																0	0	1,638,500,000	0	0	0	1,556,600,000	0	0	0	1,377,200,000	0	0	0	1,906,000,000
cash, cash equivalents and restricted cash, end of period																348,300,000	144,700,000	974,000,000	301,200,000	-73,200,000	553,700,000	856,800,000	340,500,000	273,200,000	-57,200,000	1,000,100,000	-1,652,500,000	293,900,000	1,457,500,000	1,278,300,000
reconciliation of cash, cash equivalents and restricted cash:
net (gain) loss on derivative contracts																				100,000	-100,000	-1,500,000
net realized and unrealized (gains) on investments																		-800,000
cash paid to acquire nex, net of cash received
(repayment) issuance of commercial paper
proceeds from other borrowings, net of issuance costs																																															0				0								0	0	-400,000	608,400,000	0	-300,000	-900,000	744,700,000	-1,947,000
proceeds from settlement of (premium payment for) derivative contract
common stock issued for the acquisition of nex
net realized and unrealized losses on investments																				3,800,000
issuance of commercial paper, net of maturities																				0	-100,000,000	-204,600,000	-131,400,000	-200,600,000	-222,800,000	462,300,000
settlement of derivative contracts																								0	0	16,000,000
net realized and unrealized losses (gains) on investments																						-2,900,000
income tax expense reclassified from accumulated other comprehensive income upon final sale of bm&fbovespa shares																															0	0	0	87,800,000
loss on derivative contracts
net realized and unrealized gains on investments
declaration of annual variable dividend, payable in january 2020, january 2019 and january 2018
unrealized loss on derivative contracts																								1,200,000
premium payment for derivative contract																											0	0
unrealized loss on assets held for sale
net realized and unrealized (gains) losses on privately-held equity investments
proceeds from sales of privately-held equity investments																												0
net income on derivative contracts																										14,400,000
net realized and unrealized gains on privately-held equity investments																										3,400,000	-11,500,000
loss on datacenter																																			0	0	0	27,100,000
gain on sale of bm&fbovespa shares																																0	0	-86,500,000						2,500,000
gain on sale of bolsa mexicana de valores, s.a.b de c.v.																															-300,000
proceeds from sale of bm&fbovespa shares																															0	0	0	244,000,000					69,800,000	11,300,000
proceeds from sale of bolsa mexicana de valores, s.a.b de c.v.																															4,500,000
proceeds from exercise of stock options																											1,400,000	1,900,000	4,000,000	4,200,000	6,300,000	7,500,000	12,400,000	10,500,000	22,300,000	9,500,000	13,600,000	6,400,000	12,200,000	9,700,000	13,500,000	28,600,000	26,700,000	15,100,000	7,000,000	4,500,000	20,100,000	25,500,000	15,300,000	12,800,000	2,900,000	7,700,000	3,600,000	7,900,000	600,000	700,000	1,300,000	3,200,000	6,100,000	1,600,000	2,800,000	2,100,000	5,200,000	1,500,000	11,300,000	2,400,000	9,115,000
proceeds from lease financing obligation
excess tax benefits related to employee option exercises and restricted stock vesting																																			-500,000	6,600,000	-500,000	3,900,000	400,000	5,400,000	600,000	700,000	700,000	400,000	2,000,000	900,000	1,400,000	3,300,000	1,800,000	300,000	900,000	300,000	600,000	2,800,000	-100,000	200,000			2,200,000	500,000	700,000	2,400,000					3,592,000
declaration of annual variable dividend, payable in january 2019, january 2018 and january 2017
intangible and fixed asset impairments
unrealized losses on derivative contracts																												14,500,000
gain on sale of bolsa mexicana de valores, s.a.b de c.v. shares
realized and unrealized gains on privately-held equity investments
(gain) loss on sale of bm&fbovespa shares
debt prepayment costs																																							0	0
settlement of derivative related to debt issuance																																							0	0	0	7,000,000					0				0
proceeds from finance lease obligation																																			0	0	0	130,000,000
settlement of contingent consideration																																							0
net change in cash and cash equivalents																															272,500,000	268,800,000	74,500,000	-580,800,000	448,100,000	259,400,000	15,100,000	-546,600,000	258,300,000	283,300,000	-543,800,000	328,700,000	278,200,000	50,600,000	-16,400,000	-1,416,000,000	404,700,000	97,000,000	124,600,000	238,700,000	-412,200,000	723,700,000	231,500,000	19,400,000	213,000,000	135,700,000	28,900,000	-190,500,000	287,000,000	204,600,000	-80,600,000	183,600,000	56,500,000	-244,600,000	109,500,000	41,300,000	-284,526,000
cash and cash equivalents, beginning of period																															0	0	0	1,868,600,000	0	0	0	1,692,600,000	0	0	0	1,366,100,000	0	0	0	2,469,700,000	0	0	0	1,604,700,000	0	0	0	1,042,300,000	0	0	0	855,200,000	0	0	0	260,600,000	0	0	0	297,900,000	0
cash and cash equivalents, end of period																															272,500,000	268,800,000	74,500,000	1,287,800,000	448,100,000	259,400,000	15,100,000	1,146,000,000	258,300,000	283,300,000	-543,800,000	1,694,800,000	278,200,000	50,600,000	-16,400,000	1,053,700,000	404,700,000	97,000,000	124,600,000	1,843,400,000	-412,200,000	723,700,000	231,500,000	1,061,700,000	213,000,000	135,700,000	28,900,000	664,700,000	287,000,000	204,600,000	-80,600,000	444,200,000	56,500,000	-244,600,000	109,500,000	339,200,000	-284,526,000
declaration of annual variable dividend, payable in january 2018, january 2017 and january 2016
proceeds from sale of business venture
proceeds from sale of building properties
declaration of annual variable dividend, payable in january 2017, january 2016 and january 2015
accrued proceeds from sale of bm&fbovespa shares
loss on sale of bm&fbovespa shares
loss on sale of nymex building property
declaration of annual variable dividend, payable in january 2016, january 2015 and january 2014
proceeds from sale of building property																																												0	0	7,900,000					0	0
gain on contribution of dow jones index asset group																																																			1,000,000	4,700,000
loss on sale of credit market analysis ltd.																																																			0	600,000
proceeds from sale of building properties, net of transaction costs
cash paid in business combinations, net of cash acquired
issuance of loan to unconsolidated subsidiary
proceeds from sale of credit market analysis ltd., net of cash sold with business																																																			0	0
declaration of annual variable dividend, payable in january 2015 and january 2014
undistributed net (gains) losses of unconsolidated subsidiaries																																												-20,000,000	-8,200,000	-11,000,000
purchase of noncontrolling interest
purchase of non-controlling interest in cme group index holdings llc																																																0
accrued purchase of non-controlling interest
mf global accounts receivable write-off
gain on sale of index services assets																																																							0	0
proceeds from sale of index services assets																																																							0	0
declaration of annual variable dividend, payable in january 2014
gain on contribution of dow jones index business
equity in net (gains) losses of unconsolidated subsidiaries																																																-20,400,000	-20,200,000	-17,500,000	-15,900,000
proceeds from maturities and sale of available-for-sale marketable securities
investment in business ventures
gain on contribution of dow jones index index business
net income on derivative investments																																																																			390,000
impairment of goodwill and intangible assets																																																																			0
impairment of long-term investments
amortization of debt financing costs and discount accretion																																																			2,000,000	1,300,000
proceeds from sale of long-term investments
proceeds from chicago board options exchange exercise right privileges																																																											0	0
repayments of commercial paper
class a common stock issued to bm&fbovespa sa
distribution paid to non-controlling interest																																																											0	0	0	-607,500,000
change in net unrealized securities gains																																																				109,500,000	-124,200,000	99,100,000	43,800,000	-188,000,000	-62,000,000	372,600,000	4,200,000	-10,400,000			400,000	26,300,000	8,100,000	7,100,000
change in net unrealized derivative gains
equity in net incomees of unconsolidated subsidiaries																																																					900,000	800,000	1,200,000	900,000	1,100,000	1,100,000
investment in dme holdings limited																																																					0	-22,800,000
guarantee of exercise right privileges																																																																			-35,000
change in assets and liabilities:
net change in nymex securities lending program investments																																																															0	0	151,500,000	274,400,000	-9,169,000
consideration paid in business combinations, net of cash acquired
proceeds from sale of long-term investment
purchase of bolsa mexicana de valores, s.a.b. de c.v. shares																																																											0
capital contributions to fxmarketspace limited																																																															-300,000	100,000	-900,000	-2,000,000	-3,019,000
proceeds (repayments) of commercial paper																																																													-299,900,000	200,000,000	-224,800,000	-199,900,000
net change in nymex securities lending program liabilities																																																															0	0	-157,000,000	-299,800,000	9,169,000
change in net unrealized derivatives gains																																																							100,000	200,000	100,000	500,000	3,600,000	2,800,000			5,000,000	0	4,800,000	2,400,000
credit market analysis limited impairment																																																												0
amortization of debt financing costs, net of discount accretion on debt
income tax payable																																																								-9,200,000	-164,100,000	157,200,000				146,900,000			-88,700,000	90,100,000
cash acquired upon formation of index services
proceeds from (repayments of) commercial paper
class a common stock issued to bm&fbovespa
net accretion of discounts and amortization of debt financing costs																																																									1,100,000	1,900,000	1,100,000	1,400,000	1,300,000	1,100,000	1,100,000	1,200,000	1,600,000	8,800,000
cash acquired from index services																																																													-700,000	6,100,000
recognition of in-process research and development acquired from credit market analysis limited																																																																			0
impairment of securities lending assets																																																																			2,539,000
nymex membership rights payment																																																																			0
merger-related transaction costs																																																																			-33,394,000
purchase of derivative related to bm&fbovespa sa investment
proceeds from sale of metals trading products																																																																			10,723,000
stock issuance costs in merger with nymex holdings
fair value of class a common stock, stock options and restricted stock units issued in connection with nymex holdings merger																																																																			11,519,000
fair value of class a common stock issued in exchange for bm&fbovespa sa stock
equity in losses of unconsolidated subsidiaries																																																												3,900,000	1,500,000	1,500,000	2,300,000	1,600,000	1,700,000	1,200,000	3,629,000
impairment of long-term investment
cash acquired in formation of index services
repayments of commercial paper, net of proceeds
proceeds from employee stock purchase plan																																																															700,000	0			823,000
amortization of shares issued to board of directors																																																															600,000	600,000	700,000	600,000	642,000
allowance for doubtful accounts																																																															-100,000	300,000	300,000	-400,000	-682,000
net accretion of discounts and amortization of premiums on marketable securities																																																															0	0	-400,000	-2,200,000	-4,175,000
loss on sale of metals trading products																																																																			-503,000
purchase of exercise right privileges
cash acquired in merger with cbot holdings
acquisition of credit market analysis limited, net of cash received																																																																			87,000
acquisition of nymex holdings, net of cash received
contingent consideration for liquidity direct technology, llc assets
stock issuance costs in mergers with nymex holdings and cbot holdings
repurchase of common stock, including costs
fair value of class a common stock and stock options issued in connection with cbot holdings merger
acquisition of nymex holdings, inc., net of cash received
nymex membership rights payments
excess tax benefits from option exercises and restricted stock vesting																																																																-400,000	1,200,000	400,000
dividends declared but unpaid on class a common stock
net income on derivative instruments
proceeds (repayments) of commercial paper borrowings																																																																		-858,800,000
non-cash restructuring
net accretion of discounts and amortization of financing costs on debt																																																																			7,462,000
change in assets and liabilities, net of effects from mergers with nymex holdings and cbot holdings:
proceeds from maturities of marketable securities																																																																			11,000,000
purchases of marketable securities																																																																			-199,162,000
acquisition of swapstream, net of cash received
purchase of derivative related to bm&f investment
capital contributions to onechicago, llc
proceeds from issuance of commercial paper, net of maturities																																																																			295,334,000
change in net unrealized securities gains and losses																																																																			-23,126,000
change in net unrealized derivatives gains and losses
change in foreign currency translation adjustment																																																																			-106,738,000
sale of membership shares by onechicago, llc
fair value of class a common stock issued in exchange for bm&f stock
cash flows from operating activities:
cash flows from investing activities:
cash acquired in merger with cbot holdings inc.
purchase of derivative related to bm&f bovespa sa investment
cash flows from financing activities:
stock issuance costs in merger with cbot holdings
repurchase of class a common stock
supplemental disclosure of cash flow information:
income taxes paid, net of refunds
fair value of class a common stock issued in exchange for bm&f bovespa sa stock

We provide you with 20 years of cash flow statements for CME Group stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CME Group stock. Explore the full financial landscape of CME Group stock with our expertly curated income statements.

The information provided in this report about CME Group stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.